Send to

Choose Destination
See comment in PubMed Commons below
JAMA. 2008 Mar 26;299(12):1474-6. doi: 10.1001/jama.299.12.1474.

Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs.

Author information

  • 1Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington 98101, USA.
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk